| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients
|
Srivastava, Akhil
|
|
2018
|
20 |
5 |
p. 1-11
|
article
|
| 2 |
A Population Pharmacokinetic-Pharmacodynamic Model of Pegfilgrastim
|
Brekkan, Ari
|
|
2018
|
20 |
5 |
p. 1-14
|
article
|
| 3 |
Assessment of Three-Drug Combination Pharmacodynamic Interactions in Pancreatic Cancer Cells
|
Molins, Emilie A. G.
|
|
2018
|
20 |
5 |
p. 1-15
|
article
|
| 4 |
Combining Extracellular miRNA Determination with Microfluidic 3D Cell Cultures for the Assessment of Nephrotoxicity: a Proof of Concept Study
|
Suter-Dick, Laura
|
|
2018
|
20 |
5 |
p. 1-9
|
article
|
| 5 |
Effect of Inhalation Flow Rate on Mass-Based Plume Geometry of Commercially Available Suspension pMDIs
|
Moraga-Espinoza, Daniel F.
|
|
2018
|
20 |
5 |
p. 1-12
|
article
|
| 6 |
Exact Gradients Improve Parameter Estimation in Nonlinear Mixed Effects Models with Stochastic Dynamics
|
Olafsdottir, Helga Kristin
|
|
2018
|
20 |
5 |
p. 1-13
|
article
|
| 7 |
Implementing Optimal Designs for Dose–Response Studies Through Adaptive Randomization for a Small Population Group
|
Ryeznik, Yevgen
|
|
2018
|
20 |
5 |
p. 1-15
|
article
|
| 8 |
Model-Based Residual Post-Processing for Residual Model Identification
|
Ibrahim, Moustafa M. A.
|
|
2018
|
20 |
5 |
p. 1-9
|
article
|
| 9 |
Nephrotoxicity and Kidney Transport Assessment on 3D Perfused Proximal Tubules
|
Vormann, Marianne K.
|
|
2018
|
20 |
5 |
p. 1-11
|
article
|
| 10 |
Reflections on FDA Draft Guidance for Products Containing Nanomaterials: Is the Abbreviated New Drug Application (ANDA) a Suitable Pathway for Nanomedicines?
|
Emily, Marden
|
|
2018
|
20 |
5 |
p. 1-6
|
article
|
| 11 |
Screening of Drug-Transporter Interactions in a 3D Microfluidic Renal Proximal Tubule on a Chip
|
Vriend, Jelle
|
|
2018
|
20 |
5 |
p. 1-13
|
article
|
| 12 |
Using Clinical PK/PD Studies to Support No Clinically Meaningful Differences Between a Proposed Biosimilar and the Reference Product
|
Zhu, Peijuan
|
|
2018
|
20 |
5 |
p. 1-6
|
article
|
| 13 |
Virtual Thorough QT (TQT) Trial—Extrapolation of In Vitro Cardiac Safety Data to In Vivo Situation Using Multi-Scale Physiologically Based Ventricular Cell-wall Model Exemplified with Tolterodine and Fesoterodine
|
Patel, Nikunjkumar
|
|
2018
|
20 |
5 |
p. 1-9
|
article
|
Journal description